Skip to main content
Clinical Trials/NCT01061619
NCT01061619
Active, not recruiting
Not Applicable

Pathway to Diagnosis of Ovarian Cancer: Observational Retrospective Multicenter Study

National Cancer Institute, Naples30 sites in 3 countries400 target enrollmentJanuary 2010
ConditionsOvarian Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ovarian Cancer
Sponsor
National Cancer Institute, Naples
Enrollment
400
Locations
30
Primary Endpoint
the frequency and duration of symptoms in 12 months preceding ovarian cancer diagnosis
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to describe the prediagnostic symptoms and the events along the pathway to diagnosis of women with ovarian cancer, referred for first-line chemotherapy.

Registry
clinicaltrials.gov
Start Date
January 2010
End Date
November 2024
Last Updated
3 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
National Cancer Institute, Naples
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Histological diagnosis of ovarian cancer
  • Indication for chemotherapy
  • Age \> 18 years
  • Signed informed consent

Exclusion Criteria

  • Previous chemotherapy
  • Unable or unwilling to participate in interview

Outcomes

Primary Outcomes

the frequency and duration of symptoms in 12 months preceding ovarian cancer diagnosis

Time Frame: at baseline

time intervals in weeks between prediagnostic sentinel events (onset of persistent symptoms, first physician visit, diagnosis of ovarian cancer)

Time Frame: at baseline

description of prediagnostic patient experiences according to modified Andersen's model of 'total patient delay'

Time Frame: at baseline

Study Sites (30)

Loading locations...

Similar Trials